Literature DB >> 28780933

γδ T Cells: Unexpected Regulators of Cancer Development and Progression.

Christopher Fleming1, Samantha Morrissey2, Yihua Cai1, Jun Yan3.   

Abstract

Accumulating evidence suggests a role for gamma delta (γδ) T cells as unexpected drivers of tumor development and progression. These protumoral γδ T cells are abundant in the tumor microenvironment in both mouse and human. They promote tumor progression by: (i) inducing an immunosuppressive tumor microenvironment and angiogenesis via cytokine production; (ii) functioning as regulatory T (Treg)/T helper 2 (Th2)-like cells; (iii) interfering with dendritic cell (DC) effector function; and (iv) inhibiting antitumor adaptive T cell immunity via the programmed death-1 (PD-1)-programmed death ligand-1 (PD-L1) pathway. Understanding how these cells are regulated and what their specific role in cancer is will provide insight for the development of approaches that specifically target these cells and can thereby improve the efficacy of cancer immunotherapies.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PD-1 regulation; protumoral; tumor microenvironment; γδ T cells

Mesh:

Substances:

Year:  2017        PMID: 28780933      PMCID: PMC5551453          DOI: 10.1016/j.trecan.2017.06.003

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  58 in total

1.  Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.

Authors:  Liang Rong; Ke Li; Rui Li; Hui-Min Liu; Rui Sun; Xiao-Yan Liu
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

Review 2.  Modulation of γδ T cell responses by TLR ligands.

Authors:  Daniela Wesch; Christian Peters; Hans-Heinrich Oberg; Kathrin Pietschmann; Dieter Kabelitz
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

Review 3.  Human gamma delta T cells: Evolution and ligand recognition.

Authors:  Erin J Adams; Siyi Gu; Adrienne M Luoma
Journal:  Cell Immunol       Date:  2015-05-06       Impact factor: 4.868

4.  Phenotypic characterization and prognostic impact of circulating γδ and αβ T-cells in metastatic malignant melanoma.

Authors:  Kilian Wistuba-Hamprecht; Svetlana Di Benedetto; Bastian Schilling; Antje Sucker; Dirk Schadendorf; Claus Garbe; Benjamin Weide; Graham Pawelec
Journal:  Int J Cancer       Date:  2015-09-18       Impact factor: 7.396

5.  γδ T cells recognize a microbial encoded B cell antigen to initiate a rapid antigen-specific interleukin-17 response.

Authors:  Xun Zeng; Yu-Ling Wei; Jun Huang; Evan W Newell; Hongxiang Yu; Brian A Kidd; Michael S Kuhns; Ray W Waters; Mark M Davis; Casey T Weaver; Yueh-hsiu Chien
Journal:  Immunity       Date:  2012-09-06       Impact factor: 31.745

6.  Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.

Authors:  Jian Ye; Chunling Ma; Eddy C Hsueh; Christopher S Eickhoff; Yanping Zhang; Mark A Varvares; Daniel F Hoft; Guangyong Peng
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

7.  Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.

Authors:  Guangyong Peng; Helen Y Wang; Weiyi Peng; Yukiko Kiniwa; Kook Heon Seo; Rong-Fu Wang
Journal:  Immunity       Date:  2007-07-26       Impact factor: 31.745

8.  Clonal analysis of CD4-CD8- human thymocytes expressing a T cell receptor gamma/delta chain. Direct evidence for the de novo expression of CD8 surface antigen and of cytolytic activity against tumor targets.

Authors:  M C Mingari; P Varese; C Bottino; G Melioli; A Moretta; L Moretta
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

Review 9.  Mixing Signals: Molecular Turn Ons and Turn Offs for Innate γδ T-Cells.

Authors:  Vasileios Bekiaris; John R Šedý; Carl F Ware
Journal:  Front Immunol       Date:  2014-12-18       Impact factor: 7.561

10.  Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites.

Authors:  Francesco Dieli; Fabrizio Poccia; Martin Lipp; Guido Sireci; Nadia Caccamo; Caterina Di Sano; Alfredo Salerno
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  36 in total

1.  BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.

Authors:  Kyle K Payne; Jessica A Mine; Subir Biswas; Ricardo A Chaurio; Alfredo Perales-Puchalt; Carmen M Anadon; Tara Lee Costich; Carly M Harro; Jennifer Walrath; Qianqian Ming; Evgenii Tcyganov; Andrea L Buras; Kristen E Rigolizzo; Gunjan Mandal; Jason Lajoie; Michael Ophir; Julia Tchou; Douglas Marchion; Vincent C Luca; Piotr Bobrowicz; Brooke McLaughlin; Ugur Eskiocak; Michael Schmidt; Juan R Cubillos-Ruiz; Paulo C Rodriguez; Dmitry I Gabrilovich; Jose R Conejo-Garcia
Journal:  Science       Date:  2020-08-21       Impact factor: 47.728

Review 2.  Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation.

Authors:  Shabnam Shalapour; Michael Karin
Journal:  Immunity       Date:  2019-07-16       Impact factor: 31.745

3.  Targeting breast cancer with a combination of DNT and LAG3 checkpoint blockage and its mechanism.

Authors:  Miao Wang; Yuhan Wei; Yingrui Li; Hongzhong Li; Jiangtao Jin; Yuting Lu; Qin Li
Journal:  Immun Inflamm Dis       Date:  2022-08

4.  Integrative Analysis of Biomarkers and Mechanisms in Adamantinomatous Craniopharyngioma.

Authors:  Da Lin; Wenyue Zhao; Jun Yang; Hao Wang; Hongbing Zhang
Journal:  Front Genet       Date:  2022-03-30       Impact factor: 4.599

Review 5.  Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.

Authors:  Maarten Versteven; Johan M J Van den Bergh; Elly Marcq; Evelien L J Smits; Viggo F I Van Tendeloo; Willemijn Hobo; Eva Lion
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

6.  Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints.

Authors:  Pauline Girard; Benedicte Ponsard; Julie Charles; Laurence Chaperot; Caroline Aspord
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

7.  Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging.

Authors:  Anna C Belkina; Alina Starchenko; Katherine A Drake; Elizabeth A Proctor; Riley M F Pihl; Alex Olson; Douglas A Lauffenburger; Nina Lin; Jennifer E Snyder-Cappione
Journal:  Front Immunol       Date:  2018-12-05       Impact factor: 8.786

Review 8.  Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu.

Authors:  Michela Colombo; Leonardo Mirandola; Maurizio Chiriva-Internati; Andrea Basile; Massimo Locati; Elena Lesma; Raffaella Chiaramonte; Natalia Platonova
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

9.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12

Review 10.  γδ T Cells: Crosstalk Between Microbiota, Chronic Inflammation, and Colorectal Cancer.

Authors:  Yunben Yang; Chunjing Xu; Dang Wu; Zhen Wang; Pin Wu; Lili Li; Jian Huang; Fuming Qiu
Journal:  Front Immunol       Date:  2018-06-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.